Sio Capital Management as of Dec. 31, 2022
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 45 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences Put Option | 23.4 | $63M | 574k | 110.00 | |
| Medicus Sciences Acquisition Cl A Shs | 8.7 | $23M | 2.3M | 10.07 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 7.5 | $20M | 683k | 29.60 | |
| Cigna Corp (CI) | 6.4 | $17M | 53k | 331.34 | |
| Organon & Co Common Stock (OGN) | 6.1 | $16M | 588k | 27.93 | |
| United Therapeutics Corporation (UTHR) | 5.7 | $15M | 55k | 278.09 | |
| Quest Diagnostics Incorporated Put Option (DGX) | 5.3 | $14M | 92k | 156.44 | |
| AmerisourceBergen (COR) | 5.2 | $14M | 84k | 165.71 | |
| Medtronic SHS (MDT) | 3.7 | $9.9M | 128k | 77.72 | |
| Staar Surgical Com Par $0.01 (STAA) | 2.8 | $7.6M | 157k | 48.54 | |
| Icon SHS (ICLR) | 2.4 | $6.6M | 34k | 194.25 | |
| Inogen (INGN) | 2.1 | $5.7M | 287k | 19.71 | |
| Avantor (AVTR) | 1.9 | $5.3M | 250k | 21.09 | |
| Heska Corp Com Restrc New | 1.9 | $5.2M | 84k | 62.16 | |
| Protagonist Therapeutics (PTGX) | 1.8 | $4.7M | 435k | 10.91 | |
| Novavax Com New (NVAX) | 1.3 | $3.5M | 340k | 10.28 | |
| Cymabay Therapeutics | 1.3 | $3.5M | 556k | 6.27 | |
| Pharvaris N V (PHVS) | 1.2 | $3.2M | 285k | 11.25 | |
| Merrimack Pharmaceuticals Com New (MACK) | 1.1 | $2.9M | 250k | 11.46 | |
| Reata Pharmaceuticals Cl A Put Option | 0.9 | $2.5M | 67k | 37.99 | |
| Health Sciences Acquisitions Corp 2 Ord Shs | 0.9 | $2.5M | 250k | 9.98 | |
| Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.9 | $2.5M | 249k | 9.98 | |
| Cti Biopharma | 0.7 | $2.0M | 330k | 6.01 | |
| Iveric Bio Put Option | 0.7 | $1.8M | 86k | 21.41 | |
| X4 Pharmaceuticals (XFOR) | 0.7 | $1.8M | 1.8M | 0.99 | |
| Relmada Therapeutics (RLMD) | 0.6 | $1.6M | 471k | 3.49 | |
| Modular Medical Com New (MODD) | 0.5 | $1.4M | 689k | 2.00 | |
| Merus N V (MRUS) | 0.5 | $1.4M | 88k | 15.47 | |
| Aeglea Biotherapeutics | 0.5 | $1.4M | 3.0M | 0.45 | |
| Savara (SVRA) | 0.5 | $1.3M | 866k | 1.55 | |
| Ideaya Biosciences (IDYA) | 0.5 | $1.3M | 70k | 18.17 | |
| Tyra Biosciences (TYRA) | 0.4 | $1.2M | 152k | 7.60 | |
| Moleculin Biotech | 0.4 | $1.1M | 1.0M | 1.06 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $1.0M | 136k | 7.39 | |
| Fusion Pharmaceuticals (FUSN) | 0.3 | $820k | 260k | 3.15 | |
| Connect Biopharma Holdings Ads (CNTB) | 0.2 | $519k | 598k | 0.87 | |
| Sientra | 0.2 | $517k | 2.6M | 0.20 | |
| Aslan Pharmaceuticals Ads | 0.2 | $458k | 1.3M | 0.36 | |
| Elevation Oncology (ELEV) | 0.1 | $342k | 360k | 0.95 | |
| Nextcure (NXTC) | 0.1 | $183k | 130k | 1.41 | |
| Caremax Com Cl A | 0.1 | $159k | 44k | 3.65 | |
| Vincerx Pharma Com New (VINC) | 0.0 | $104k | 102k | 1.02 | |
| Nyxoah Sa SHS (NYXH) | 0.0 | $80k | 16k | 4.99 | |
| Humacyte *w Exp 08/27/202 (HUMA) | 0.0 | $20k | 50k | 0.41 | |
| Neoleukin Therapeutics | 0.0 | $20k | 38k | 0.51 |
